Implanted subcutaneous intravascular catheters. Diagnostic intravascular catheters.
Mechanical heart valves.
Saline-filled internal inflatable breast prostheses. Permanent pacemaker electrodes. Another group of about 15 devices will fall under summary reporting near the end of the year, according to Mary Weick-Brady, FDA Center for Devices and Radiological Health's Division of Postmarket Surveillance team leader. Eventually, some events may be dropped from the reporting requirement altogether, Weick-Brady speculates. However, this could be years down the road and is likely to be a tough sell for many at the agency.